Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry

Bente Glintborg; Tina Marie Kringelbach; E. Høgdall; Inge Juul Sørensen; Dorte Vendelbo Jensen; A. G. Loft; O. Hendricks; I. M. J. Hansen; N. Bolstad; D. J. Warren; J. Gehin; G. Goll; Kathrine Lederballe Grøn; G. Eng; C. Enevold; C. H. Nielsen; J. S. Johansen; Merete Lund Hetland

Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry

Bente Glintborg, Tina Marie Kringelbach, E. Høgdall, Inge Juul Sørensen, Dorte Vendelbo Jensen, A. G. Loft, O. Hendricks, I. M. J. Hansen, N. Bolstad, D. J. Warren, J. Gehin, G. Goll, Kathrine Lederballe Grøn, G. Eng, C. Enevold, C. H. Nielsen, J. S. Johansen, Merete Lund Hetland

Department for Rheumatology and Spine Diseases

Original language	English
Article number	OP10
Journal	Scandinavian Journal of Rheumatology
Volume	45
Issue number	Suppl. 128
Pages (from-to)	6-7
Number of pages	2
ISSN	0300-9742
Publication status	Published - 2016

Cite this

Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Hansen, I. M. J., Bolstad, N., Warren, D. J., Gehin, J., Goll, G., Grøn, K. L., Eng, G., Enevold, C., Nielsen, C. H., Johansen, J. S., & Hetland, M. L. (2016). Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry. Scandinavian Journal of Rheumatology, 45(Suppl. 128), 6-7. Article OP10.

Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry. / Glintborg, Bente; Kringelbach, Tina Marie; Høgdall, E. et al.
In: Scandinavian Journal of Rheumatology, Vol. 45, No. Suppl. 128, OP10, 2016, p. 6-7.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Glintborg, B, Kringelbach, TM, Høgdall, E, Sørensen, IJ , Jensen, DV, Loft, AG, Hendricks, O, Hansen, IMJ, Bolstad, N, Warren, DJ, Gehin, J, Goll, G, Grøn, KL, Eng, G, Enevold, C, Nielsen, CH, Johansen, JS & Hetland, ML 2016, 'Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry', Scandinavian Journal of Rheumatology, vol. 45, no. Suppl. 128, OP10, pp. 6-7.

Glintborg B, Kringelbach TM, Høgdall E, Sørensen IJ , Jensen DV, Loft AG et al. Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry. Scandinavian Journal of Rheumatology. 2016;45(Suppl. 128):6-7. OP10.

Glintborg, Bente ; Kringelbach, Tina Marie ; Høgdall, E. et al. / Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry. In: Scandinavian Journal of Rheumatology. 2016 ; Vol. 45, No. Suppl. 128. pp. 6-7.

@article{f3137374a9b14335a187d0ed6d9e2482,

title = "Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry",

author = "Bente Glintborg and Kringelbach, \{Tina Marie\} and E. H{\o}gdall and S{\o}rensen, \{Inge Juul\} and Jensen, \{Dorte Vendelbo\} and Loft, \{A. G.\} and O. Hendricks and Hansen, \{I. M. J.\} and N. Bolstad and Warren, \{D. J.\} and J. Gehin and G. Goll and Gr{\o}n, \{Kathrine Lederballe\} and G. Eng and C. Enevold and Nielsen, \{C. H.\} and Johansen, \{J. S.\} and Hetland, \{Merete Lund\}",

year = "2016",

language = "English",

volume = "45",

pages = "6--7",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Taylor and Francis Ltd.",

number = "Suppl. 128",

}

TY - ABST

T1 - Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry

AU - Glintborg, Bente

AU - Kringelbach, Tina Marie

AU - Høgdall, E.

AU - Sørensen, Inge Juul

AU - Jensen, Dorte Vendelbo

AU - Loft, A. G.

AU - Hendricks, O.

AU - Hansen, I. M. J.

AU - Bolstad, N.

AU - Warren, D. J.

AU - Gehin, J.

AU - Goll, G.

AU - Grøn, Kathrine Lederballe

AU - Eng, G.

AU - Enevold, C.

AU - Nielsen, C. H.

AU - Johansen, J. S.

AU - Hetland, Merete Lund

PY - 2016

Y1 - 2016

M3 - Conference abstract in journal

SN - 0300-9742

VL - 45

SP - 6

EP - 7

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

IS - Suppl. 128

M1 - OP10

ER -